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Background
In contemporary drug allergy diagnostics PCDPT holds
significant value. We analyzed whether results of PCDPT
correlate with the results of other diagnostic procedures
such as in vivo skin testing and in vitro laboratory tests on
betalactam and non-betalactam antibiotics performed in
our department during the last 5 years.
Method
All the patients underwent PCDPTs to betalactam and
non-betalactam antibiotics from the 1st of October 2008
to the 1st of October 2013 in our department reported
about one or more adverse side reactions to antibiotic in
the background and underwent standard diagnostic proce-
dures prior PCDPT. We compared the results of diagnos-
tic procedures such as in vivo skin testing and in vitro
laboratory tests to the results of PCDPT.
Results
PCDPTs to antibiotics were performed either to confirm
(11% of cases) or to deny (55% of cases) the diagnosis of
antibiotic allergy or to find an alternative drug if the
allergy to certain antibiotics was confirmed by prior
diagnostics (34% of cases). PCDPTs to antibiotics were
performed in 56 patients: 18% were to classical betalac-
tam antibiotics (without cephalosporins)and 82% to
non-betalactam antibiotics. In 89% of cases no reaction
to both placebo and drug was seen. 7% of PCDPTs
showed objectified reaction to drug, 4% a non-objectifi-
able or questionable reaction to drug and no cases of a
non-objectifiable reaction to placebo without any reac-
tion to drug were seen. Prior to PCDPT we performed
available in vivo skin testing and in vitro laboratory
tests. In 42% of cases we measured specific IgE antibo-
dies to antibiotics and in all cases they were negative. In
32% of patients we performed a basophil activation test
and in all cases it was negative. In 90% of cases we per-
formed a skin prick test, 94% of tests were negative, in
4% dermatographic urticaria was seen and in 2% reac-
tion was questionable. We performed intracutaneous
test in 56% of cases, in 98% it was negative and in 2% a
questionable reaction was observed. In 63% of patients a
patch test was performed and in all cases it was nega-
tive. In all cases that patients showed a positive objecti-
fied reaction to the antibiotic in PCDPT the tests
performed prior to PCDPT were negative.
Conclusion
PCDPT remains a gold standard in drug allergy diagnos-
tics. In vivo skin testing and in vitro laboratory tests may
be falsely wrong and therefore it requires additional
PCDPT for a final diagnostic statement.
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